Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder.

Health Affairs
Barbara Andraka-Christou

Abstract

Social discourse about the opioid crisis in the US has focused on White populations, even though opioid-related deaths have grown at a higher rate among people of color than among non-Hispanic White people in recent years. Medications for opioid use disorder (OUD) are the gold standard for treating OUD and preventing overdose but are underused among people with OUD, with disproportionately low treatment initiation and retention among people of color. Methadone, which is highly stigmatized and has a more burdensome treatment regimen, is the predominant medication for OUD available to people of color. To address disparities in the initiation and retention of treatment using medication for OUD, policy makers should consider strategies such as Medicaid expansion, increased grant funding for federally qualified health centers to provide buprenorphine treatment, retention of temporary telehealth policies that allow remote buprenorphine induction, and regulatory changes to allow methadone treatment in office-based practices.

References

Mar 31, 2005·Journal of Consulting and Clinical Psychology·Nancy M PetryFrancis Simcic
Jan 13, 2006·Journal of General Internal Medicine·Lisa A CooperThomas S Inui
Jun 5, 2008·Health Services Research·Harold A Pollack, Thomas D'Aunno
Nov 21, 2008·Evaluation and Program Planning·Jeanne C MarshHee-Choon Shin
Jan 11, 2012·Qualitative Health Research·Julie Harris, Karen McElrath
Apr 2, 2013·Journal of Community Health·Samina T SyedLisa K Sharp
Apr 10, 2013·Journal of Substance Abuse Treatment·Jan GryczynskiRobert P Schwartz
Sep 1, 2015·Journal of Health Care for the Poor and Underserved·Lynn M WielenBenjamin F Miller
Feb 3, 2016·Drug and Alcohol Dependence·Georgios KourounisLampros Samartzis
Apr 12, 2016·JAMA Internal Medicine·Julia B NathRenee Y Hsia
Mar 18, 2017·Journal of Ethnicity in Substance Abuse·Courtney McKnightDavid C Perlman
Apr 28, 2017·BMJ : British Medical Journal·Luis SordoRoberto Pastor-Barriuso
May 21, 2017·Current Psychiatry Reports·Anjalee SharmaRobert P Schwartz
May 31, 2017·Journal of Substance Abuse Treatment·Jamey J ListerDavid M Ledgerwood
Nov 22, 2017·Substance Use & Misuse·Alexandrea E HatcherHelena Hansen
Jun 1, 2016·World Medical & Health Policy·Marian Moser Jones
Jun 23, 2018·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Bradley D SteinRosalie Liccardo Pacula
Aug 28, 2018·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Keturah James, Ayana Jordan
Jan 25, 2019·The American Journal of Drug and Alcohol Abuse·Arthur Robin WilliamsMark Olfson
May 9, 2019·JAMA Psychiatry·Pooja A LagisettyDonovan T Maust
Dec 14, 2019·Drug and Alcohol Dependence·Gwen LaphamUNKNOWN PROUD Collaborative Investigators
Jan 8, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Amanda J AbrahamPeter D Friedmann
Feb 6, 2020·JAMA Network Open·Sarah E WakemanDarshak M Sanghavi
May 15, 2020·PloS One·Aisling Máire O'ConnorFiona Boland
Sep 8, 2020·Journal of Substance Abuse Treatment·Lori Uscher-PinesHaiden A Huskamp
Nov 4, 2020·Journal of Substance Abuse Treatment·Katharine CioeSandra A Springer
Mar 16, 2021·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·Phillip M HughesBayla Ostrach

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.